Publication | Closed Access

Exposure–response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane

Breast OncologyMedicinePathologyBreast CancerCancer TreatmentExposure–response AnalysesOncologyRadiation OncologyTumor BiologyTrastuzumab Emtansine